Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Biochem Pharmacol. 2018 Mar 30;152:187–200. doi: 10.1016/j.bcp.2018.03.027

Table 2.

Substitutions in AT1R’s CaM-binding domains

Domain targeted Wild-type sequence Mutant sequence
SMD2 (AT1R125–141) DRYLAIVHPMKSRLRRT DQALAIVHPMKSQLRQT
SMD3 (AT1R215–242) YTLIWKALKKAYEIQKNKPRNDDIFKII YTLIAKALKKAAEIQKNQPRNDDIAKII
SMD4JM (AT1R309–327) FKRYFLQLLKYIPPKAKSH AKRYALQLLKAIPPKAQSH